Temaz and Sodium fluoride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Sodium fluoride (fluoride). Common drug interactions include chest discomfort among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Sodium fluoride. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Sodium fluoride?

Sodium fluoride has active ingredients of fluoride. It is often used in dental cavities. eHealthMe is studying from 1,216 Sodium fluoride users. Check the latest studies of Sodium fluoride.



On Jul, 12, 2026

45 people who take Temaz and Sodium fluoride together, and have interactions are studied.

Temaz and Sodium fluoride drug interactions.

What are the common drug interactions of Temaz and Sodium Fluoride, by gender? *:

female:

  1. Chest discomfort
  2. Hypoaesthesia eye (reduced sense of touch or sensation on eyes)
  3. Oropharyngeal discomfort (pain or irritation of oropharynx)
  4. Throat tightness
  5. Pain
  6. Vomiting
  7. Confusional state
  8. Abdominal discomfort
  9. Adverse drug reaction
  10. Alopecia (absence of hair from areas of the body)

male:

  1. Renal failure (kidney dysfunction)
  2. Anxiety
  3. Bone density decreased
  4. Emotional distress
  5. Nephropathy (damage to or disease of a kidney)
  6. Pain
  7. Tooth loss
  8. Chronic kidney disease
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

What are the common drug interactions of Temaz and Sodium Fluoride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Anxiety
  2. Chest discomfort
  3. Hypoaesthesia eye (reduced sense of touch or sensation on eyes)
  4. Oropharyngeal discomfort (pain or irritation of oropharynx)
  5. Throat tightness

10-19:

n/a

20-29:

n/a

30-39:

  1. Anxiety
  2. Chest discomfort
  3. Hypoaesthesia eye (reduced sense of touch or sensation on eyes)
  4. Oropharyngeal discomfort (pain or irritation of oropharynx)
  5. Throat tightness
  6. Bone density decreased
  7. Emotional distress
  8. Nephropathy (damage to or disease of a kidney)
  9. Pain
  10. Renal failure (kidney dysfunction)

40-49:

  1. Drug tolerance decreased
  2. Duodenal ulcer perforation (untreated ulcer can burn through the wall of the stomach)
  3. Dyspepsia (indigestion)
  4. Folliculitis (infection of hair root)
  5. Gait disturbance
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Glossodynia (a burning or painful sensation in the tongue)
  8. Hand deformity
  9. Hypersensitivity
  10. Impaired healing

50-59:

  1. Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
  2. Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)
  3. Hypoxia (low oxygen in tissues)
  4. Pain
  5. Progressive multiple sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord)
  6. Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
  7. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Alanine aminotransferase increased
  10. Chills (felling of cold)

60+:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Pain: 12 people, 26.67%
  2. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 10 people, 22.22%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 22.22%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 10 people, 22.22%
  5. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 10 people, 22.22%
  6. Depression: 10 people, 22.22%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 10 people, 22.22%
  8. Headache (pain in head): 10 people, 22.22%
  9. Indigestion: 10 people, 22.22%
  10. Metastases To Bone (cancer spreads to bone): 9 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Sodium fluoride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Temaz and Sodium fluoride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sodium fluoride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sodium fluoride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on temazepam and fluoride (the active ingredients of Temaz and Sodium fluoride, respectively), and Temaz and Sodium fluoride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: